Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Exosomes & Liquid Biopsies Europe 2018

Paul Robbins's Biography



Paul Robbins, Professor, Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School

Paul D. Robbins, Ph.D. is Professor Department of Biochemistry, Molecular Biology, and Biophysics, and the Institute on the Biology of Aging and Metabolism, University of Minnesota Medical School, Minneapolis, MN. Previously he was a Professor of Microbiology and Molecular Genetics, Director of Basic Research for the Molecular Medicine Institute and Co-Director of the Paul Wellstone Cooperative Muscular Research Center at the University of Pittsburgh School of Medicine as well as Interim Director of Molecular & Cellular Oncology at the University of Pittsburgh Cancer Institute. He received his B.A. from Haverford College, his Ph.D. from the University of California at Berkeley and worked as a post-doctoral fellow in the laboratory of Dr. Richard Mulligan at the Whitehead Institute for Biomedical Research at MIT. He has co-authored over 320 peer-reviewed manuscripts and 170 book chapters and reviews and edited four books. He was a member of the NIH PathB Study Section, Chair of the Italian Telethon Scientific Review Committee and a member of the Telethon Scientific Advisory Board. He also was a member of the Scientific Review Board of National Gene Vector Laboratory and the Board of Directors of the American Society of Gene Therapy and currently is a member of the National Institute on Aging Interventions Testing Program. He has co-founded two biotechnology companies and currently serves on the Scientific Advisory Boards of four biotechnology companies. Dr. Robbins’ research is focused on developing therapeutic approaches, including small molecules, biologics and stem cells, to extend healthspan and reduce frailty using mouse models of aging.

Paul Robbins Image

Stem Cell-Derived Extracellular Vesicles (EVs) as Therapeutics For Extending Healthspan

Friday, 26 October 2018 at 11:30

Add to Calendar ▼2018-10-26 11:30:002018-10-26 12:30:00Europe/LondonStem Cell-Derived Extracellular Vesicles (EVs) as Therapeutics For Extending HealthspanExosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

A universal characteristic of aging is loss of tissue regenerative potential due to stem cell dysfunction, contributing to the dramatic increase in the risk of morbidity and mortality. We have used both naturally aged mice and mouse models of accelerated aging to demonstrate that transplantation of young, functional adult stem cells results in an extension of healthspan. In addition, we have demonstrated that stem cell-derived EVs are a key factor for conferring the observed extension of healthspan by young stem cells. Progress towards developing clinically-relevant approaches using stem cell-derived extracellular vesicles to age-related pathologies will be presented. In addition, progress towards using circulating EVs as biomarkers of biological age will be presented.


Add to Calendar ▼2018-10-24 00:00:002018-10-26 00:00:00Europe/LondonExosomes and Liquid Biopsies Europe 2018Exosomes and Liquid Biopsies Europe 2018 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com